21 – 30 of 254
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Pre- and Postoperative Antioxidant Use, Aryl Hydrocarbon Receptor (AhR) Activation and Clinical Outcome in Different Treatment Groups of Breast Cancer Patients
(
- Contribution to journal › Article
-
Mark
Register data support the long-term safety of the use of ultra-hypofractionated radiotherapy for localised prostate cancer previously seen in the phase 3 trial HYPO-RT-PC : ESTRO 2024 congress report
2024)(
- Other contribution › Web publication
-
Mark
Probably Not!
(
- Contribution to journal › Letter
-
Mark
Register data on long-term morbidity after prostate ultra-hypofractionation in the HYPO-RT-PC trial
(
- Contribution to journal › Published meeting abstract
-
Mark
Anti-Müllerian hormone and fertility in women after childhood cancer treatment : Association with current infertility risk classifications
(
- Contribution to journal › Article
-
Mark
Symptom experience and symptom distress in patients with malignant brain tumor treated with proton therapy : A five-year follow-up study
(
- Contribution to journal › Article
-
Mark
Surgery Combined with Local Implantation of Doxorubicin-Functionalized Hydroxyapatite Halts Tumor Growth and Prevents Bone Destruction in an Aggressive Osteosarcoma
(
- Contribution to journal › Article
-
Mark
Bias and precision of SPECT-based 177Lu activity-concentration estimation using a ring-configured solid-state versus a dual-headed anger system
(
- Contribution to journal › Article
-
Mark
Stereotactic body radiotherapy as metastasis-directed therapy in oligometastatic prostate cancer: a systematic review and meta-analysis of randomized controlled trials
(
- Contribution to journal › Article
-
Mark
Histopathology-validated gross tumor volume delineations of intraprostatic lesions using PSMA-positron emission tomography/multiparametric magnetic resonance imaging
(
- Contribution to journal › Article